Literature DB >> 2703968

Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.

A Herchuelz1, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems, J Douchamps.   

Abstract

Nonsteroidal anti-inflammatory drugs have been shown to decrease the natriuretic response to loop diuretics in many but not all studies. Recently, indomethacin was shown not to affect the natriuretic response to the new loop diuretic torasemide in healthy volunteers. Inasmuch as sodium balance has been reported to modify the effect of indomethacin on furosemide-induced natriuresis in dogs, we investigated the effect of indomethacin, under two sodium balances (50 and 150 mEq/day), on the natriuretic response to two doses of torasemide in six healthy volunteers. Under the low sodium diet, indomethacin reduced the natriuretic response to torasemide like that to furosemide. In contrast, on the normal sodium diet, indomethacin failed to affect the natriuretic response to torasemide. Indomethacin reduced base-line and diuretic-induced increase in plasma renin activity, plasma angiotensin II levels and urinary excretion of prostaglandin 6-keto F1 alpha to a similar extent under the two sodium diets. Our data show that indomethacin reduces the natriuretic response to torasemide in humans. Dietary sodium restriction is a significant determinant of the interaction between nonsteroidal anti-inflammatory drugs and loop diuretics in healthy volunteers, presumably because it allows loop diuretics to provoke an increase in renal blood flow which participates in their natriuretic action and is blocked by nonsteroidal anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703968

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital (MRRH) in western Uganda: prevalence, clinical importance and associated factors.

Authors:  S J Lubinga; E Uwiduhaye
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

Review 2.  Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.

Authors:  J Feenstra; D E Grobbee; A Mosterd; B H Stricker
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

3.  Torasemide: a pharmacoeconomic review of its use in chronic heart failure.

Authors:  M Young; G L Plosker
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 4.  Torasemide. A review of its pharmacological properties and therapeutic potential.

Authors:  H A Friedel; M M Buckley
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 5.  Torasemide. An update of its pharmacological properties and therapeutic efficacy.

Authors:  C J Dunn; A Fitton; R N Brogden
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

6.  How to use diuretics in heart failure.

Authors:  Elizabeth M Volz; G Michael Felker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-12

Review 7.  Benefits and risks of torasemide in congestive heart failure and essential hypertension.

Authors:  D C Brater
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

Review 8.  Torasemide prolonged release.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

9.  Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients.

Authors:  Berna Solak; Seyyid Bilal Acikgoz; Savas Sipahi; Teoman Erdem
Journal:  Int Urol Nephrol       Date:  2016-01-14       Impact factor: 2.370

Review 10.  The causes, consequences, and treatment of left or right heart failure.

Authors:  Pablo Pazos-López; Jesús Peteiro-Vázquez; Ana Carcía-Campos; Lourdes García-Bueno; Juan Pablo Abugattas de Torres; Alfonso Castro-Beiras
Journal:  Vasc Health Risk Manag       Date:  2011-04-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.